Biocorp Earns CE Mark for Insulin Tracker
Biocorp has gained approval in Europe for the Mallya smart sensor, a device that records key treatment information for diabetic patients.
The sensor connects conventional insulin pens to a mobile app, tracking the selected dose, date and time of injection. The automated recording eliminates the need for logbooks and manual recordkeeping.
The device also creates a summary report of a patient’s injected doses over the previous three months.